Phase I Study of Ixabepilone and Temsirolimus in Adult Patients With Advanced Solid Tumors

Trial Profile

Phase I Study of Ixabepilone and Temsirolimus in Adult Patients With Advanced Solid Tumors

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 29 May 2017

At a glance

  • Drugs Ixabepilone (Primary) ; Temsirolimus (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Dec 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
    • 05 Dec 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
    • 09 Nov 2015 Results presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top